Effect of low-dose combined oral contraceptive on aerobic capacity and anaerobic threshold level in active and sedentary young women


Autoria(s): REBELO, Ana Cristina S.; ZUTTIN, Roberta S.; VERLENGIA, Rozangela; CESAR, Marcelo de C.; SA, Marcos Felipe Silva de; SILVA, Ester da
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2010

Resumo

Background: The purpose of this study was to evaluate the effect of long-term use of oral contraceptives (DC) containing 0.20 mg of ethinylestradiol (EE) combined with 0.15 mg of gestodene (GEST) on the peak aerobic capacity and at the anaerobic threshold (AT) level in active and sedentary young women. Study Design: Eighty-eight women (23 +/- 2.1 years old) were divided into four groups active-OC (G1), active-NOC (G2), sedentary-OC (G3) and sedentary-NOC (G4) and were submitted to a continuous ergospirometric incremental test on a cycloergometer with 20 to 25 W min(-1) increments. Data were analyzed by two-way ANOVA with Tukey post hoc test. Level of significance was set at 5%. Results: The OC use effect for the variables relative and absolute oxygen uptake VO(2) mL kg(-1) min(-1); VO(2), L min(-1), respectively), carbon dioxide output (VCO(2), L min(-1)), ventilation (VE, L min(-1)), heart rate (HR, bpm), respiratory exchange ratio (RER) and power output (W) data, as well as the interaction between OC use and exercise effect on the peak of test and at the AT level did not differ significantly between the active groups (G1 and G2) and the sedentary groups (G3 and G4). As to the exercise effect, for all variables studied, it was noted that the active groups presented higher values for the variables VO(2), VCO(2), VE and power output (p<.05) than the sedentary groups. The RER and HR were similar (p>.05) at the peak and at the AT level between G1 vs. G3 and G2 vs. G4. Conclusions: Long-term use of OC containing EE 0.20 mg plus GEST 0.15 mg does not affect aerobic capacity at the peak and at the AT level of exercise tests. (C) 2010 Elsevier Inc. All rights reserved.

CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico[370448/2007-3]

FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo[2006/56788-1]

Identificador

CONTRACEPTION, v.81, n.4, p.309-315, 2010

0010-7824

http://producao.usp.br/handle/BDPI/24523

10.1016/j.contraception.2009.11.005

http://dx.doi.org/10.1016/j.contraception.2009.11.005

Idioma(s)

eng

Publicador

ELSEVIER SCIENCE INC

Relação

Contraception

Direitos

restrictedAccess

Copyright ELSEVIER SCIENCE INC

Palavras-Chave #Oral contraceptive #Ethinylestradiol #Gestodene #Aerobic capacity #MENSTRUAL-CYCLE #CHLORMADINONE ACETATE #EXERCISE PERFORMANCE #METABOLISM #RESPONSES #DESOGESTREL #TRIAL #PHASE #USERS #Obstetrics & Gynecology
Tipo

article

original article

publishedVersion